Energy giant BP has bagged the high-profile general counsel of GlaxoSmithKline (GSK), Rupert Bondy, to replace veteran general counsel Peter Bevan when he retires later this year.

Bevan joined BP's chemicals arm in 1970 and became group general counsel 22 years later, securing his position as one of the UK's best-known general counsel.

Bevan, who is set to retire at the end of April, told Legal Week: "I will miss the place but you have to retire sometime. I will decide over the next few months what I will do next. I have a few ideas but nothing concrete as yet."

Bondy joined SmithKline Beecham from City law firm Lovells in 1995 and was made general counsel at the pharmaceuticals giant in 2001 following the company's merger with Glaxo Wellcome in 2000. He is set to start at BP in March, reporting to chief executive Tony Hayward.

GSK has already kicked off the search for Bondy's replacement, in a move sure to be closely watched by the company's roster of external advisers, which includes chief corporate adviser Slaughter and May.

BP, which drew up its first-ever panel for top-tier cross-border deals at the end of 2006, is also advised by firms including Linklaters, Norton Rose, Simmons & Simmons and McGrigors.

US giants Sullivan & Cromwell, Kirkland & Ellis, Baker & McKenzie and Mayer Brown have also previously acted for the group.

More in-house news, comment and analysis

For thousands of the best legal jobs, click here.